Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Is a |
Product containing hydralazine and isosorbide dinitrate (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Osmotic diuretic (substance) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydralazine (substance) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Isosorbide dinitrate (substance) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has manufactured dose form |
Oral tablet |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Is a |
Hydralazine-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Is a |
Product containing isosorbide dinitrate in oral dosage form |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydralazine (substance) |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Hydralazine (substance) |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
37.5 |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Isosorbide dinitrate (substance) |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Isosorbide dinitrate (substance) |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
20 |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Isosorbide dinitrate (substance) |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
20 |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Hydralazine (substance) |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
37.5 |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Hydralazine (substance) |
false |
Inferred relationship |
Some |
2 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Isosorbide dinitrate (substance) |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has unit of presentation |
Tablet (unit of presentation) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Is a |
Product containing hydralazine and isosorbide in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Is a |
Nitrogen and/or nitrogen compound-containing product |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Is a |
Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|